Literature DB >> 9740709

Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.

A Horiuchi1, R Osada, K Nakayama, T Toki, T Nikaido, S Fujii.   

Abstract

A case of a yolk sac tumor (YST) with an ovarian endometrioid adenocarcinoma arising from endometriosis in a postmenopausal woman is described. Clinically, the case showed an aggressive course and did not respond to chemotherapy; the patient died of her disease 6 months after the operation. Histologically, the tumor consisted predominantly of an endometrioid adenocarcinoma, but it also showed microscopic features characteristic of YST. The tumor also contained benign endometriotic lesions with direct transition to the endometrioid adenocarcinoma. Immunohistochemical study revealed that not only the YST, but also the endometrioid adenocarcinoma was partly positive for alpha-fetoprotein. There was an inverse relationship between the endometriosis and the endometrioid adenocarcinoma in terms of the expression of sex steroid receptors and p53: adenocarcinoma cells were positive for p53 but negative for sex steroid receptors, whereas endometriotic epithelial cells were positive for sex steroid receptors but negative for p53. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9740709     DOI: 10.1006/gyno.1998.5048

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

1.  Bilateral ovarian mixed epithelial adenocarcinoma in a postmenopausal woman with unilateral ovarian yolk sac tumor component.

Authors:  Qin Chen; Xiaoduan Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

2.  Atypical epithelial changes and mutant p53 gene expression in ovarian endometriosis.

Authors:  H Bayramoğlu; E Düzcan
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

3.  Establishment and characterization of an ovarian yolk sac tumor patient-derived xenograft model.

Authors:  Manling Luo; Yuanqiao He; Baogang Xie; Shiyun Li; Fuqiang Gan; Shouhua Zhang; Puying Luo
Journal:  Pediatr Surg Int       Date:  2021-05-24       Impact factor: 1.827

4.  Molecular characterization of uterine and ovarian tumors with mixed epithelial and germ cell features confirms frequent somatic derivation.

Authors:  Stephanie L Skala; Chia-Jen Liu; Aaron M Udager; Andrew P Sciallis
Journal:  Mod Pathol       Date:  2020-05-13       Impact factor: 7.842

5.  P53 codon 11, 72, and 248 gene polymorphisms in endometriosis.

Authors:  Yao-Yuan Hsieh; Chich-Sheng Lin
Journal:  Int J Biol Sci       Date:  2006-07-12       Impact factor: 6.580

6.  Post-menopausal presentation of yolk sac germ cell tumour.

Authors:  V L Parker; P Sanderson; V Naik; C Quincey; K Farag
Journal:  Gynecol Oncol Rep       Date:  2014-11-15

Review 7.  Ovarian yolk sac tumor in postmenopausal females: A case series and a literature review.

Authors:  Yao Wang; Jiaxin Yang; Mei Yu; Dongyan Cao; Ying Zhang; Xuan Zong; Keng Shen
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

8.  Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.

Authors:  Wei-Ting Chao; Chia-Hao Liu; Chiung-Ru Lai; Yi-Jen Chen; Chi-Mu Chuang; Peng-Hui Wang
Journal:  J Ovarian Res       Date:  2018-06-22       Impact factor: 4.234

9.  A case of ovarian endometrioid adenocarcinoma with yolk sac differentiation and Lynch syndrome.

Authors:  Janhvi Sookram; Brooke Levin; Julieta Barroeta; Kathy Kenley; Pallav Mehta; Lauren S Krill
Journal:  Gynecol Oncol Rep       Date:  2019-01-11

10.  Identification of displaced endometrial glands and embryonic duct remnants in female fetal reproductive tract: possible pathogenetic role in endometriotic and pelvic neoplastic processes.

Authors:  Jean Bouquet de Jolinière; Jean Marc Ayoubi; Guy Lesec; Pierre Validire; Alexandre Goguin; Luca Gianaroli; Jean Bernard Dubuisson; Anis Feki; Jean Gogusev
Journal:  Front Physiol       Date:  2012-12-03       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.